Results
1 -
5 of
5
(Click
here to explore results)
- An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors. Yan Li, Weimin Gao, Feng Li, Jinghui Wang, Jingxiao Zhang, Yinfeng Yang, Shuwei Zhang, Ling Yang
, Mol. BioSyst.
, 2013
, 9
, 2266
- Decorated 6,6′,7,7′-tetrahydro-1H,1′H-2,3′-biindole scaffold as promising candidate for recognition of the CDK2 allosteric site. Antonio Rescifina, Angela Scala, Maria Teresa Sciortino, Ivana Colao, Gabriel Siracusano, Antonino Mazzaglia, Ugo Chiacchio, Giovanni Grassi
, Med. Chem. Commun.
, 2015
, 6
, 311
- Multi-pathway cellular analysis of compound selectivity. Michael K. Hancock, Connie S. Lebakken, Jun Wang, Kun Bi
, Mol. BioSyst.
, 2010
, 6
, 1834
- Emerging approaches to CDK inhibitor development, a structural perspective. Ian Hope, Jane A. Endicott, Jessica E. Watt
, RSC Chem. Biol.
, 2023
, 4
, 146
- Inversion kinetics of some E/Z 3-(benzylidene)-2-oxo-indoline derivatives and their in silico CDK2 docking studies. Hany S. Mansour, Hend A. A. Abd El-wahab, Ahmed M. Ali, Tarek Aboul-Fadl
, RSC Adv.
, 2021
, 11
, 7839